Group 1 - The company announced the issuance of 640 shares of Mandi Inc. at a price of $1.0 per share as part of its incentive measures for directors, senior management, and employees [1] - Of the 640 shares, 290 shares will be issued to Mandi Group Limited and 350 shares to Hero Grand, based on the selected participants' past contributions to Mandi Group [1] - The total value of the rewards amounts to $640.00, representing approximately 6.84% of Mandi's issued share capital as of the announcement date, and 6.4% after the issuance [1] Group 2 - The issuance of rewards aligns with the objectives of the Mandi equity incentive plan, aimed at recognizing and rewarding selected participants for their contributions to Mandi and the group's development [2] - The terms of the rewards are deemed fair and reasonable, benefiting the ongoing development and stability of Mandi, the group, and the shareholders [2] - The board, including independent non-executive directors, believes that the rewards and related terms are in the overall interest of Mandi, the group, and the shareholders [2]

智通财经APP讯，三生制药(01530)发布公告，于2025年10月20日(交易时段后)，作为集团激励其董事、 高级管理层及雇员表现措施的一部分，公司全资附属公司Mandi Inc.的董事会已决议按每股 Mandi股份 1.0美元的代价向选定参与者发行640股Mandi股份作为奖励，其中290股 Mandi股份将根据Mandi股权激 励计划发行予该信托的控股公司Mandi Group Limited 及350股Mandi股份将发行予Hero Grand。向Hero Grand及Mandi Group Limited发行Mandi 股份的代价乃经考虑(其中包括)选定参与者过往对Mandi及集团 作出的贡献后厘定。 ...